Skog
Frank I. Skog, Shoreview, MN US
Patent application number | Description | Published |
---|---|---|
20090078057 | RESIDUAL TORQUE ANALYZER - A system for detecting fastener movement and measuring a residual torque in a fastener joint, including a device for applying torque to a stationary fastener in a tightened state and measuring torque and angle of rotation. The device includes a sensing system that has a gyroscope that provides a signal corresponding to the angle of rotation of the device as it applies torque to the fastener, and a torque transducer that provides a signal corresponding to the torque applied to the fastener by the device. The device also includes a computing unit in communication with the sensing system and adapted to receive the signal corresponding to an angle of rotation of the device and the signal corresponding to the torque applied to the fastener, and determine a torque at a moment of initial movement of the fastener. | 03-26-2009 |
Hakan Skog, Billdal SE
Patent application number | Description | Published |
---|---|---|
20080295374 | Device for a Display Tower and a Method to Produce the Same - A new display has a base and a post, and also where appropriate, a sleeve. The display is shipped flat in a small container, and a recipient erects the post and then positions the base over it. The post is anchored to the base by adhesive. Should a sleeve be used, this is positioned over the post. The display can now carry products on spears or shelves that are inserted in or through the post. A message may be printed on the post or the sleeve. In repeated campaigns, only the sleeve need be sent out. In this way, a rational and cost-effective solution is obtained, where as much as possible of the material can be re-used. A method of manufacturing the display is also described. | 12-04-2008 |
Isaac Skog, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20150019268 | DETERMINATION OF ACTIVITY RATE OF PORTABLE ELECTRONIC EQUIPMENT - A method for obtaining activity rate of a portable electronic device ( | 01-15-2015 |
20150153201 | REPORTING OF METER INDICATION | 06-04-2015 |
Johan Skog, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110195426 | NUCLEIC ACIDS ANALYSIS - The present invention is partly based on the discovery that adverse factors can prevent an effective extraction of nucleic acids from a biological sample and that novel and unexpected agents and steps may be used to mitigate or remove the adverse factors, thereby dramatically improving the quality of the extracted nucleic acids. As such, one aspect of this invention is a novel method for extracting high quality nucleic acids from a biological sample. The high quality extractions obtained by the novel methods described herein are characterized by high yield and high integrity, making the extracted nucleic acids useful for various applications in which high quality nucleic acid extractions are preferred, e.g., a diagnosis, prognosis or therapy evaluation for a medical condition. | 08-11-2011 |
Johan K. Skog, New York, NY US
Patent application number | Description | Published |
---|---|---|
20130295574 | Method for Isolation of Nucleic Acid Containing Particles and Extraction of Nucleic Acids Therefrom - A method for extracting nucleic acids from a biological sample by isolating nucleic acid-containing particles from the biological sample by one or more centrifugation procedures, performing one or more steps to mitigate adverse factors that prevent or might prevent high quality nucleic acid extraction, and extracting nucleic acids from the isolated particles. The centrifugation procedures are performed at a speed not exceeding about 200,000 g. The extracted nucleic acids contain both 18S and 28S rRNA. | 11-07-2013 |
Johan Karl Olav Skog, Charlestown, MA US
Patent application number | Description | Published |
---|---|---|
20150176073 | USE OF MICROVESICLES IN DIAGNOSIS, PROGNOSIS, AND TREATMENT OF MEDICAL DISEASES AND CONDITIONS - The invention provides a novel method for detecting the presence or absence of one or more transfer RNAs (tRNAs) contained in microvesicles from a subject. The invention also provides a novel method for detecting the presence or absence of one or more human endogenous retrovirus elements (HERV) in microvesicles from a subject. The methods disclosed is directed to aiding diagnosis, prognosis, minotring and evaluation of a disease or other medical condition in a subject. | 06-25-2015 |
20150252428 | USE OF MICROVESICLES IN DIAGNOSIS, PROGNOSIS, AND TREATMENT OF MEDICAL DISEASES AND CONDITIONS - The present invention discloses methods for diagnosing or prognosing a disease or medical condition in a subject by detecting the presence or absence of BRAF mutant nucleic acids from nucleic acids extracted from microvesicles from a biological sample. The present invention also discloses methods for assessing the responsiveness or determining a treatment regimen for a subject in need thereof by detecting the presence or absence of BRAF mutant nucleic acids from nucleic acids extracted from microvesicles from a biological sample. Methods for isolating microvesicles and extracting DNA and/or RNA from the microvesicles are also described. | 09-10-2015 |
20150353920 | METHODS FOR ISOLATING MICROVESICLES - The invention provides novel methods for isolating microvesicles from a biological sample and for extracting nucleic acids from the microvesicles. | 12-10-2015 |
20160024491 | Method for Isolation of Nucleic Acid Containing Particles and Extraction of Nucleic Acids Therefrom - A method for extracting nucleic acids from a biological sample by isolating nucleic acid-containing particles from the biological sample by one or more centrifugation procedures, performing one or more steps to mitigate adverse factors that prevent or might prevent high quality nucleic acid extraction, and extracting nucleic acids from the isolated particles. The centrifugation procedures are performed at a speed not exceeding about 200,000 g. The extracted nucleic acids contain both 18S and 28S rRNA. | 01-28-2016 |
Johan Karl Olav Skog, New York, NY US
Patent application number | Description | Published |
---|---|---|
20130202559 | Use of Microvesicles in the Treatment of Medical Conditions - This invention relates generally to populations of microvesicles containing or otherwise associated with viral particles, methods of producing these purified populations, and methods of using these purified populations in a variety of diagnostic, therapeutic and/or prophylactic indications. | 08-08-2013 |
Johan Karl Olov Skog, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110053157 | USE OF MICROVESICLES IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF MEDICAL DISEASES AND CONDITIONS - The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a′ subject by detecting a biomarker in microvesicles isolated from a biological, sample from the subject. Moreover, disclosed subject matter is directed to methods of diagnosis, monitoring a disease by determining the concentration of microvesicles within a biological sample; methods of delivering a nucleic acid or protein to a target all by administering microvesicles that contain said nucleic acid or protein; methods for performing a body fluid transfusion by introducing a microvesicle-free or microvesicle enriched fluid fraction into a patient. | 03-03-2011 |
20120142001 | METHOD FOR ISOLATION OF NUCLEIC ACID CONTAINING PARTICLES AND EXTRACTION OF NUCLEIC ACIDS THEREFROM - A method for extracting nucleic acids from a biological sample by isolating nucleic acid-containing particles from the biological sample by one or more centrifugation procedures, performing one or more steps to mitigate adverse factors that prevent or might prevent high quality nucleic acid extraction, and extracting nucleic acids from the isolated particles. The centrifugation procedures are performed at a speed not exceeding about 200,000 g. The extracted nucleic acids contain both 18S and 28S rRNA. | 06-07-2012 |
20130029339 | USE OF MICROVESICLES IN ANALYZING KRAS MUTATIONS - Microvesicles are small membrane vesicles that either shed or bud off eukarotic cells. Analysis of the nucleic acid content of microvesicles may be useful in detecting the presence or absence of genetic aberrations. This invention discloses novel methods of diagnosing, prognosing, monitoring, or treating a disease, such as cancer, or other medical condition in a subject involving analyzing one or more nucleic acids contained within an isolated microvesicle for the presence or absence of one or more Kras genetic aberrations. | 01-31-2013 |
20130040833 | USE OF MICROVESICLES IN ANALYZING NUCLEIC ACID PROFILES - The invention concerns gene signatures obtained from microvesicles and a method of applying these gene signatures in helping to determine a biological condition. The determination of a biological condition may aid, for example, the diagnosis, prognosis, and therapy treatment selection for a disease in a subject. | 02-14-2013 |
20140045915 | CANCER-RELATED BIOLOGICAL MATERIALS IN MICROVESICLES - Disclosed herein are methods for assaying a biological sample from a subject by analyzing components of microvesicle fractions in aid of risk, diagnosis, prognosis or monitoring of or directing treatment of the subject for, a disease or other medical condition in the subject. Also disclosed are methods of treatment and identifying biomarkers using a microvesicle fraction of a subject. Kits, pharmaceutical compositions, and profiles related to the methods are also disclosed. | 02-13-2014 |
20140147839 | MICROVESICLE-BASED ASSAYS - Methods are disclosed herein for assaying a biological sample or a bodily fluid obtained from a subject by isolating, obtaining or using a microvesicle fraction from the biological sample or bodily fluid and detecting in the microvesicle fraction the presence or absence of a genetic aberration in an IDH1, IDH2, TP53, PTEN, CDKN2A, NF1, EGFR, RB1, PIK3CA, or BRAF gene. The methods may be used for aiding the diagnosis, prognosis, monitoring, or therapy selection in relation to a disease or other medical condition (e.g., a glioma) in a subject. | 05-29-2014 |
20140212871 | Nucleic Acid Extraction from Heterogeneous Biological Materials - Methods for extracting high quality nucleic acids from a heterogenous collection of nucleic acid-containing materials from a biological sample are disclosed. The heterogenous collection of nucleic-acid containing materials may contain cells or microvesicles, or both. The extractions obtained by the methods described herein are characterized by high yield and high integrity, making the extracted nucleic acids useful for various applications in which high quality nucleic acid extractions are preferred, e.g., a diagnosis, prognosis, or therapy evaluation for a medical condition. | 07-31-2014 |
20150322532 | USE OF MICROVESICLES IN ANALYZING MUTATIONS - Microvesicles are small membrane vesicles that either shed or bud off eukarotic cells. Analysis of the nucleic acid content of microvesicles may be useful in detecting the presence or absence of genetic aberrations. This invention discloses novel methods of diagnosing, prognosing, monitoring, or treating a disease, such as cancer, or other medical condition in a subject involving analyzing one or more nucleic acids contained within an isolated microvesicle for the presence or absence of one or more Kras genetic aberrations. | 11-12-2015 |
20160002736 | USE OF MICROVESICLES IN ANALYZING NUCLEIC ACID PROFILES - The invention concerns gene signatures obtained from microvesicles and a method of applying these gene signatures in helping to determine a biological condition. The determination of a biological condition may aid, for example, the diagnosis, prognosis, and therapy treatment selection for disease in a subject. | 01-07-2016 |
Johan Karl Olov Skog, Charlestown, MA US
Patent application number | Description | Published |
---|---|---|
20100196426 | USE OF MICROVESICLES IN DIAGNOSIS AND PROGNOSIS OF MEDICAL DISEASES AND CONDITIONS - The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a subject by detecting a biomarker in microvesicles isolated from a biological sample from the subject. | 08-05-2010 |
20110003704 | USE OF MICROVESICLES IN DIAGNOSIS AND PROGNOSIS OF MEDICAL DISEASES AND CONDITIONS - The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a subject by detecting a biomarker in microvesicles isolated from a biological sample from the subject. | 01-06-2011 |
20130131194 | USE OF MICROVESICLES IN DIAGNOSIS AND PROGNOSIS OF MEDICAL DISEASES AND CONDITIONS - The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a subject by detecting a biomarker in microvesicles isolated from a biological sample from the subject. | 05-23-2013 |
20140194319 | USE OF MICROVESICLES IN DIAGNOSIS AND PROGNOSIS OF MEDICAL DISEASES AND CONDITIONS - The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a subject by detecting a biomarker in microvesicles isolated from a biological sample from the subject. | 07-10-2014 |
20140194613 | USE OF MICROVESICLES IN DIAGNOSIS AND PROGNOSIS OF MEDICAL DISEASES AND CONDITIONS - The presently disclosed subject matter is directed to methods of aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a subject by detecting a biomarker in microvesicles isolated from a biological sample from the subject. | 07-10-2014 |
20150038335 | CEREBROSPINAL FLUID ASSAY - The present invention is directed to methods of isolating particles, such as nucleic acid-containing particles or microvesicles, from a biological sample and extracting nucleic acids therefrom, wherein the biological sample is cerebrospinal fluid. The present invention further provides methods for aiding diagnosis, prognosis, monitoring and evaluation of a disease or other medical condition in a subject by detecting a biomarker associated with a disease or medical condition thereof. | 02-05-2015 |
Johan Karl Olov Skog, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20160075788 | A Novel EGFR Variant - The present invention features a novel EGFR variant, EGFRvVI, and methods for detecting the novel EGFR variant. The novel EGFR variant is preferentially expressed in some cancers. Methods for detecting EGFRvVI may aid in the diagnosis, prognosis, and therapeutic assessment of a subject. | 03-17-2016 |
Robert Bengt Skog, Hasselby SE
Patent application number | Description | Published |
---|---|---|
20120036274 | System and method for adapting information content according to the capability of the access bearer - A communication system is adapted to provide access to application information on an application server utilizing a specific one of multiple radio access types. Access is provided via an access network using an access bearer. The capability of the specifically requested access bearer is sent to the application server to tailor the application information content according to the capability of the specific access bearer. The information content is then transmitted to the requesting device. | 02-09-2012 |
20150026300 | System and Method for Adapting Information Content According to the Capability of the Access Bearer - A communication system is adapted to provide access to application information on an application server utilizing a specific one of multiple radio access types. Access is provided via an access network using an access bearer. The capability of the specifically requested access bearer is sent to the application server to tailor the application information content according to the capability of the specific access bearer. The information content is then transmitted to the requesting device. | 01-22-2015 |
20160088061 | SYSTEM AND METHOD FOR ADAPTING INFORMATION CONTENT ACCORDING TO THE CAPABILITY OF THE ACCESS BEARER - A communication system is adapted to provide access to application information on an application server utilizing a specific one of multiple radio access types. Access is provided via an access network using an access bearer. The capability of the specifically requested access bearer is sent to the application server to tailor the application information content according to the capability of the specific access bearer. The information content is then transmitted to the requesting device. | 03-24-2016 |
Robert B. Skog, Hasselby SE
Patent application number | Description | Published |
---|---|---|
20130035078 | Call-Tracking - A method for call-tracking, call-tracking systems, an HTTP proxy server computer program, web server hosts, web server computer programs and computer program products are disclosed. The method comprises the following steps: forwarding a request for a web page; receiving a reply message comprising a second telephone number; retrieving and storing a first telephone number, the second telephone number, a time associated with the forwarding of the reply message, and a service provider indicator; receiving a trigger message comprising two telephone numbers; determining whether the two telephone numbers correspond to the first telephone number and the second telephone number; and, if the two telephone numbers correspond, determining, based on a time difference, whether the call has been made within a predetermined time or predetermined time interval; and, if the call has been made within the predetermined time or predetermined time interval, store information related to the call. | 02-07-2013 |
Sven Skog, Huddinge SE
Patent application number | Description | Published |
---|---|---|
20100311081 | PREDICTING CANCER PROGRESSION - A method of predicting the likelihood of cancer relapse in a patient undergoing treatment for cancer is provided. The binding response level of an immunoreactive material (IM) comprising thymidine kinase 1 (TK1) protein is determined in a body fluid sample of a patient and the likelihood of relapse of the cancer disease is predicted based on this determined IM binding response level. Those patients that run a risk of cancer progress and relapse 1-15 years after the cancer treatment may be identified directly by the IM binding response level within a few months following initiation of the treatment. | 12-09-2010 |
Terje Skog, Nykirke NO
Patent application number | Description | Published |
---|---|---|
20080236278 | Electrical device with covering - The invention relates to a device comprising a sensor chip and a structure housing the sensor chip. The structure is covered by a mold compound and is fabricated from a ceramic or a glass material. | 10-02-2008 |
20080296776 | Method of Manufacturing Electrical Conductors for a Semiconductor Device - A method of manufacturing an electrical conductor for a semiconductor device having one or more layers includes etching from a first surface to a second surface of at least one layer of the device to form a channel having a wall extending from the first surface to the second surface. The channel defines a gap extending from the first surface to the second surface. An insulating layer is provided on the channel wall. Conductive material is patterned on the channel wall to form multiple separate electrical conductors, which are insulated from material of the at least one layer by the insulating layer, thereon, such that the gap that extends from the first surface to the second surface is maintained. A corresponding semiconductor device is also provided. | 12-04-2008 |
20080297974 | Method of Manufacturing Capacitive Elements for a Capacitive Device - A method of manufacturing capacitive elements for a capacitive device which comprises one or more layers is provided. At least one layer is etched from a first surface to a second surface thereof to form two sections of the layer, such that the sections are movable relative to one another, and such that a wall extending from the first surface to the second surface is formed on each of the two sections, the walls defining a gap therebetween. An etching step forms multiple recesses in each wall such that multiple capacitive elements are defined between adjacent recesses, the capacitive elements of one wall being offset from those of the other wall when the sections are stationary with respect to one another. A corresponding capacitive device is also provided. | 12-04-2008 |